Peter Holownia

816 total citations
22 papers, 656 citations indexed

About

Peter Holownia is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Peter Holownia has authored 22 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Reproductive Medicine and 6 papers in Molecular Biology. Recurrent topics in Peter Holownia's work include Ovarian function and disorders (6 papers), Reproductive Biology and Fertility (4 papers) and Sexual Differentiation and Disorders (4 papers). Peter Holownia is often cited by papers focused on Ovarian function and disorders (6 papers), Reproductive Biology and Fertility (4 papers) and Sexual Differentiation and Disorders (4 papers). Peter Holownia collaborates with scholars based in United Kingdom, United States and Czechia. Peter Holownia's co-authors include John W. Honour, Howard S. Jacobs, Peter C. Hindmarsh, N. A. Armar, Hugh H. G. McGarrigle, Gillian C.L. Lachelin, C. G. D. Brook, Suzanne Crowley, Christopher P. Price and David Newman and has published in prestigious journals such as Analytical Chemistry, Clinical Chemistry and Fertility and Sterility.

In The Last Decade

Peter Holownia

22 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Holownia United Kingdom 15 219 193 167 142 90 22 656
Brian Little United Kingdom 19 184 0.8× 94 0.5× 109 0.7× 94 0.7× 14 0.2× 59 1.3k
Pirjo Hedberg Finland 13 102 0.5× 137 0.7× 108 0.6× 93 0.7× 46 0.5× 21 533
Zhengpin Wang China 15 38 0.2× 232 1.2× 326 2.0× 269 1.9× 29 0.3× 32 1.1k
Pertti Mörsky Finland 13 65 0.3× 71 0.4× 123 0.7× 82 0.6× 19 0.2× 32 570
Pirjo Tanner Finland 15 129 0.6× 59 0.3× 160 1.0× 71 0.5× 37 0.4× 20 585
Yukihiro Umemoto Japan 16 43 0.2× 159 0.8× 138 0.8× 68 0.5× 16 0.2× 69 632
Mohamad H. Rahimy United States 14 51 0.2× 35 0.2× 76 0.5× 113 0.8× 12 0.1× 30 499
Zhansong Zhou China 18 82 0.4× 24 0.1× 153 0.9× 46 0.3× 35 0.4× 58 785
Masahiko Ishikawa Japan 13 18 0.1× 117 0.6× 43 0.3× 60 0.4× 23 0.3× 35 335
Stephen D. Lyons Australia 12 61 0.3× 190 1.0× 203 1.2× 106 0.7× 22 0.2× 19 768

Countries citing papers authored by Peter Holownia

Since Specialization
Citations

This map shows the geographic impact of Peter Holownia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Holownia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Holownia more than expected).

Fields of papers citing papers by Peter Holownia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Holownia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Holownia. The network helps show where Peter Holownia may publish in the future.

Co-authorship network of co-authors of Peter Holownia

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Holownia. A scholar is included among the top collaborators of Peter Holownia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Holownia. Peter Holownia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Midgley, Paula, Peter Holownia, John A. Smith, et al.. (2001). Plasma Cortisol, Cortisone and Urinary Glucocorticoid Metabolites in Preterm Infants. Neonatology. 79(2). 79–86. 16 indexed citations
2.
Holownia, Peter, et al.. (2001). Effects of the Ionic Environment, Charge, and Particle Surface Chemistry for Enhancing a Latex Homogeneous Immunoassay of C-Reactive Protein. Analytical Chemistry. 73(14). 3417–3425. 31 indexed citations
4.
Holownia, Peter, et al.. (2000). Plasma preparation from whole blood using ultrasound. Ultrasound in Medicine & Biology. 26(5). 881–888. 25 indexed citations
5.
Holownia, Peter, et al.. (2000). Clarification of plasma from whole human blood using ultrasound. Ultrasonics. 38(1-8). 654–656. 15 indexed citations
6.
Midgley, Paula, et al.. (1998). Adrenal Function in Preterm Infants: ACTH May Not Be the Sole Regulator of the Fetal Zone. Pediatric Research. 44(6). 887–893. 25 indexed citations
7.
OSTLERE, L.S., G Rumsby, Peter Holownia, et al.. (1998). Carrier status for steroid 21‐hydroxylase deficiency is only one factor in the variable phenotype of acne. Clinical Endocrinology. 48(2). 209–215. 48 indexed citations
8.
Holownia, Peter, et al.. (1998). Development and validation of an automated latex-enhanced immunoassay for prealbumin. Clinical Chemistry. 44(6). 1316–1324. 12 indexed citations
9.
Thakkar, Hansa, et al.. (1997). Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca® analyzer. Clinical Chemistry. 43(1). 109–113. 46 indexed citations
10.
Holownia, Peter, et al.. (1997). Adaptation of latex-enhanced assay for percent glycohemoglobin to a Dade Dimension® analyzer. Clinical Chemistry. 43(1). 76–84. 18 indexed citations
11.
Noonan, K., et al.. (1996). Effect of different storage temperatures, sample collection procedures and immunoassay methods on osteocalcin measurement.. PubMed. 34(10). 841–4. 12 indexed citations
12.
Holownia, Peter, et al.. (1993). A clinical evaluation of a direct radioimmunoassay of testosterone. Clinica Chimica Acta. 214(1). 31–43. 4 indexed citations
13.
Midgley, Paula, et al.. (1993). ADRENAL FUNCTION IN PRETERM INFANTS. Pediatric Research. 33(1 Suppl). S71–S71. 13 indexed citations
14.
Holownia, Peter, et al.. (1992). 11β-Hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries. Fertility and Sterility. 58(4). 713–718. 20 indexed citations
15.
Holownia, Peter, E.J. Owen, Gerard S. Conway, Jonathan Round, & John W. Honour. (1992). Studies to confirm the source of 11ß-hydroxyandrostenedione. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 875–880. 18 indexed citations
16.
Holownia, Peter, et al.. (1992). 11 beta-hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries.. PubMed. 58(4). 713–8. 21 indexed citations
17.
Holownia, Peter, E.J. Owen, Richard Hampl, Howard S. Jacobs, & John W. Honour. (1991). The determination of 11β-hydroxyandrostenedione in human follicular fluid and plasma. The Journal of Steroid Biochemistry and Molecular Biology. 38(3). 389–398. 6 indexed citations
18.
Crowley, Suzanne, Peter C. Hindmarsh, Peter Holownia, John W. Honour, & C. G. D. Brook. (1991). The use of low doses of ACTH in the investigation of adrenal function in man. Journal of Endocrinology. 130(3). 475–479. 122 indexed citations
19.
Armar, N. A., Hugh H. G. McGarrigle, John W. Honour, et al.. (1990). Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertility and Sterility. 53(1). 45–49. 151 indexed citations
20.
Stanhope, R, et al.. (1987). Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.. PubMed. 14(3). 183–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026